Mangoceuticals, Inc.
MGRX
$1.73
$0.074.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.63% | -23.94% | 5.49% | -27.43% | -40.53% |
| Total Depreciation and Amortization | 3,746.59% | 4,578.40% | 2,955.42% | 101.33% | 216.67% |
| Total Amortization of Deferred Charges | -200.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 172.27% | 110.65% | 11.20% | 101.03% | 44.47% |
| Change in Net Operating Assets | -46.91% | -113.50% | 4,809.70% | 3,393.30% | 1,819.23% |
| Cash from Operations | 2.51% | 0.53% | 30.49% | 8.70% | -23.52% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | 1,957.14% | 247.39% | 239.48% |
| Total Debt Issued | 200.00% | -28.57% | -- | -- | 187,400.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 105.04% | -5.04% | -81.61% | -72.90% | -77.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 53.33% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.37% | 164.39% | -41.50% | -33.83% | -55.88% |
| Foreign Exchange rate Adjustments | 25.00% | -2,100.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.16% | 101.58% | -1,308.53% | -419.98% | -183.39% |